In high ovarian responders, a dual trigger of triptorelin plus HCG was associated with prevention of severe ovarian hyperstimulation syndrome compared with standard-dose or low-dose HCG trigger.
In plain wordsIn high ovarian responders, a dual trigger of triptorelin plus HCG was linked to prevention of severe ovarian hyperstimulation syndrome compared with HCG-only triggers.
- Outcome
- DecreaseSevere ovarian hyperstimulation syndrome
- Study
n = 226
- Comparator
- Standard-dose (10000 IU) HCG trigger and low-dose (8000 IU) HCG trigger
- Outcome group
- Adverse events · Reproductive and sexual health
Source sentences
Our evidence demonstrated that dual trigger is capable of preventing severe OHSS while still maintaining excellent high quality embryo rate in in high ovarian responders of GnRH-antagonist protocols.
3 context sentences(design, population, supporting numbers)
In this paper, a retrospective cohort study was conducted to the high ovarian responders in GnRH-antagonist protocols of IVF/ICSI cycles.
Standard dosage of HCG trigger (10000 IU of recombinant HCG) versus dual trigger (0.2 mg of triptorelin and 2000 IU of recombinant HCG) and low-dose HCG trigger (8000IU of recombinant HCG) were used for final oocyte maturation.
Our study included 226 couples with high ovarian responders in GnRH-antagonist protocols of IVF/ICSI cycles.
In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).